Immunogene therapy with fusogenic nanoparticles modulates macrophage response to Staphylococcus aureus
Published 2018 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Immunogene therapy with fusogenic nanoparticles modulates macrophage response to Staphylococcus aureus
Authors
Keywords
-
Journal
Nature Communications
Volume 9, Issue 1, Pages -
Publisher
Springer Nature
Online
2018-05-11
DOI
10.1038/s41467-018-04390-7
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Self-Sealing Porous Silicon-Calcium Silicate Core-Shell Nanoparticles for Targeted siRNA Delivery to the Injured Brain
- (2016) Jinyoung Kang et al. ADVANCED MATERIALS
- Non-viral nucleic acid containing nanoparticles as cancer therapeutics
- (2016) Kristen L. Kozielski et al. Expert Opinion on Drug Delivery
- Porous silicon–graphene oxide core–shell nanoparticles for targeted delivery of siRNA to the injured brain
- (2016) Jinmyoung Joo et al. Nanoscale Horizons
- Protection and Delivery of Anthelmintic Protein Cry5B to Nematodes Using Mesoporous Silicon Particles
- (2015) Chia-Chen Wu et al. ACS Nano
- Improved stability and biocompatibility of nanostructured silicon drug carrier for intravenous administration
- (2015) Simo Näkki et al. Acta Biomaterialia
- Porous silicon nanoparticles as biocompatible contrast agents for magnetic resonance imaging
- (2015) M. B. Gongalsky et al. APPLIED PHYSICS LETTERS
- Optimizing the therapeutic efficacy of cisplatin PEGylated liposomes via incorporation of different DPPG ratios: In vitro and in vivo studies
- (2015) Ehsan Marzban et al. COLLOIDS AND SURFACES B-BIOINTERFACES
- Nano- and micro-based inhaled drug delivery systems for targeting alveolar macrophages
- (2015) Wing-Hin Lee et al. Expert Opinion on Drug Delivery
- TLR8 SensesStaphylococcus aureusRNA in Human Primary Monocytes and Macrophages and Induces IFN-β Production via a TAK1–IKKβ–IRF5 Signaling Pathway
- (2015) Bjarte Bergstrøm et al. JOURNAL OF IMMUNOLOGY
- Liposome-Based Engineering of Cells To Package Hydrophobic Compounds in Membrane Vesicles for Tumor Penetration
- (2015) Junsung Lee et al. NANO LETTERS
- IRF5 controls both acute and chronic inflammation
- (2015) Miriam Weiss et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Selective photosensitizer delivery into plasma membrane for effective photodynamic therapy
- (2014) Jiyoung Kim et al. JOURNAL OF CONTROLLED RELEASE
- Nanotoxicity: a key obstacle to clinical translation of siRNA-based nanomedicine
- (2014) Hui Yi Xue et al. Nanomedicine
- Could Silencing IRF5 Improve Healing of a Myocardial Infarct Through the Reprogramming of the Macrophage Population? ∗
- (2013) Jennifer L. Hall et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- In Vivo Silencing of the Transcription Factor IRF5 Reprograms the Macrophage Phenotype and Improves Infarct Healing
- (2013) Gabriel Courties et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- A window onto siRNA delivery
- (2013) Yuhua Wang et al. NATURE BIOTECHNOLOGY
- Image-based analysis of lipid nanoparticle–mediated siRNA delivery, intracellular trafficking and endosomal escape
- (2013) Jerome Gilleron et al. NATURE BIOTECHNOLOGY
- Efficiency of siRNA delivery by lipid nanoparticles is limited by endocytic recycling
- (2013) Gaurav Sahay et al. NATURE BIOTECHNOLOGY
- Identification and Characterization of Receptor-Specific Peptides for siRNA Delivery
- (2012) Yin Ren et al. ACS Nano
- Delivery of Small Interfering RNA by Peptide-Targeted Mesoporous Silica Nanoparticle-Supported Lipid Bilayers
- (2012) Carlee E. Ashley et al. ACS Nano
- RNAi-based nanomedicines for targeted personalized therapy
- (2012) Ala Daka et al. ADVANCED DRUG DELIVERY REVIEWS
- Liposomal drug delivery systems: From concept to clinical applications
- (2012) Theresa M. Allen et al. ADVANCED DRUG DELIVERY REVIEWS
- Peptides as Targeting Elements and Tissue Penetration Devices for Nanoparticles
- (2012) Erkki Ruoslahti ADVANCED MATERIALS
- In vivo targeting of alveolar macrophages via RAFT-based glycopolymers
- (2012) Eun-Ho Song et al. BIOMATERIALS
- KAP1/TRIM28: An inhibitor of IRF5 function in inflammatory macrophages
- (2012) H.L. Eames et al. IMMUNOBIOLOGY
- Understanding the Phase Behavior of Coarse-Grained Model Lipid Bilayers through Computational Calorimetry
- (2012) Jocelyn M. Rodgers et al. JOURNAL OF PHYSICAL CHEMISTRY B
- Fusion-Triggered Switching of Enzymatic Activity on an Artificial Cell Membrane
- (2012) Masaru Mukai et al. SENSORS
- Is RNAi Dead?
- (2011) Arthur M Krieg MOLECULAR THERAPY
- Therapeutic siRNA silencing in inflammatory monocytes in mice
- (2011) Florian Leuschner et al. NATURE BIOTECHNOLOGY
- IRF5 promotes inflammatory macrophage polarization and TH1-TH17 responses
- (2011) Thomas Krausgruber et al. NATURE IMMUNOLOGY
- Targeting Nrf2 Signaling Improves Bacterial Clearance by Alveolar Macrophages in Patients with COPD and in a Mouse Model
- (2011) C. J. Harvey et al. Science Translational Medicine
- Sustained Release of a Monoclonal Antibody from Electrochemically Prepared Mesoporous Silicon Oxide
- (2010) Jennifer S. Andrew et al. ADVANCED FUNCTIONAL MATERIALS
- Sustained Small Interfering RNA Delivery by Mesoporous Silicon Particles
- (2010) Takemi Tanaka et al. CANCER RESEARCH
- Origins and Evolution of Antibiotic Resistance
- (2010) J. Davies et al. MICROBIOLOGY AND MOLECULAR BIOLOGY REVIEWS
- Porous Nanoparticle Supported Lipid Bilayers (Protocells) as Delivery Vehicles
- (2009) Juewen Liu et al. JOURNAL OF THE AMERICAN CHEMICAL SOCIETY
- Particle size-dependent organ distribution of gold nanoparticles after intravenous administration
- (2008) Wim H. De Jong et al. BIOMATERIALS
- A combinatorial library of lipid-like materials for delivery of RNAi therapeutics
- (2008) Akin Akinc et al. NATURE BIOTECHNOLOGY
Become a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get StartedAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started